跳转至内容
Merck
所有图片(6)

文件

M3633

Sigma-Aldrich

4-甲基伞形酮基β-D-葡萄糖苷

β-glucosidase substrate, fluorogenic, ≥99% (HPLC), powder

别名:

MUD

登录查看公司和协议定价
所有图片(6)

About This Item

经验公式（希尔记法）:
C16H18O8
CAS号:
18997-57-4
分子量:
338.31
Beilstein:
94672
EC號碼:
242-736-7
MDL號碼:
MFCD00063694
分類程式碼代碼:
12352204
PubChem物質ID:
24896859
NACRES:
NA.32

product name

4-甲基伞形酮基β-D-葡萄糖苷, β-glucosidase substrate

化驗

≥99% (HPLC)

形狀

powder

溶解度

DMF: 50 mg/mL, clear, colorless to faintly yellow

螢光

λex 316 nm; λem 372 nm (pH 9.1)
λex 360 nm; λem 449 nm (Reaction product)

儲存溫度

−20°C

SMILES 字串

CC1=CC(=O)Oc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)ccc12

InChI

1S/C16H18O8/c1-7-4-12(18)23-10-5-8(2-3-9(7)10)22-16-15(21)14(20)13(19)11(6-17)24-16/h2-5,11,13-17,19-21H,6H2,1H3/t11-,13-,14+,15-,16-/m1/s1

InChI 密鑰

YUDPTGPSBJVHCN-YMILTQATSA-N

正在寻找类似产品? 访问 产品对比指南

應用

4-甲基伞形酮基β-D-葡萄糖苷可用来作为以下反应的底物：
  • 原发性海马神经元富含溶菌酶部分葡糖神经酰胺酶β 酶活性分析
  • 酵母发酵过程中β-葡萄糖苷酶分析
  • 巨噬细胞细胞系(RAW)中的葡萄糖脑苷脂酶1（GBA1）-相关葡萄糖苷酶活性分析

生化／生理作用

4-甲基伞形酮基β-D-葡萄糖苷是一种合成糖苷酶底物。它可用作来自肠球菌的葡萄糖苷酶底物。

其他說明

2024年CiteAb奖——成功的帕金森研究供应商(2024 CiteAb Award Winner for Supplier Succeeding in Parkinson′s Research)

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

A Rashidi et al.
Bone marrow transplantation, 51(12), 1561-1564 (2016-08-16)
Post-transplant cyclophosphamide (PT-Cy) is the backbone of GvHD prophylaxis following haploidentical hematopoietic cell transplantation (haplo-HCT). PT-Cy has also been used in matched related (MRD) and unrelated (MUD) settings. It is not known whether outcomes are similar between haplo-HCT and MRD/MUD
Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations
Li H, et al.
Autophagy, 15(1), 113-130 (2019)
An Improved Helferich Method for the alphabeta-Stereoselective Synthesis of 4-Methylumbelliferyl Glycosides for the Detection of Microorganisms
Wei X, et al.
Molecules (Basel), 20(12), 21681-21699 (2015)
Samantha G Scharenberg et al.
Nature communications, 11(1), 3327-3327 (2020-07-06)
Gaucher disease is a lysosomal storage disorder caused by insufficient glucocerebrosidase activity. Its hallmark manifestations are attributed to infiltration and inflammation by macrophages. Current therapies for Gaucher disease include life-long intravenous administration of recombinant glucocerebrosidase and orally-available glucosylceramide synthase inhibitors.
HEPES activates a MiT/TFE-dependent lysosomal-autophagic gene network in cultured cells: A call for caution
Tol MJ, et al.
Autophagy, 14(3), 437-449 (2018)
查看所有相关文献

商品

Probiotics and Human Health

Probiotics exhibit an inhibitory effect on pathogens, help prevent chronic intestinal inflammatory diseases or atopic syndromes, and support the immune system.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门